Junjie Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 10

Top Venues

Scientific reports

Journal of personalized medicine

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Linfeng Li, Qidong Cai, Zeyu Wu, Xizhe Li, Wolong Zhou, Liqing Lu, Bin Yi, Ruimin Chang, Heng Zhang, Yuanda Cheng, Chunfang Zhang, Junjie Zhang
Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific reports 13 (1) (2023)
Wolong Zhou, Yuanda Cheng, Linfeng Li, Heng Zhang, Xizhe Li, Ruimin Chang, Xiaoxiong Xiao, Liqing Lu, Bin Yi, Yang Gao, Chunfang Zhang, Junjie Zhang
Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma. Journal of personalized medicine 13 (3) (2023)
Junjie Zhang, Ran Xu, Qiang Lu, Zhenzhou Xu, Jianye Liu, Pei Li, Yaqun Zhang, Chuanchi Zhou, Lufeng Luo, Wei Tang, Zhenting Wang, Manman Cao, Jian Cao, Genming Xu, Long Wang
A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma. Cancers 15 (3) (2023)
Wolong Zhou, Yuanda Cheng, Linfeng Li, Heng Zhang, Xizhe Li, Ruimin Chang, Xiaoxiong Xiao, Liqing Lu, Bin Yi, Yang Gao, Chunfang Zhang, Junjie Zhang
Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma. Journal of personalized medicine 13 (3) (2023)
Linfeng Li, Qidong Cai, Zeyu Wu, Xizhe Li, Wolong Zhou, Liqing Lu, Bin Yi, Ruimin Chang, Heng Zhang, Yuanda Cheng, Chunfang Zhang, Junjie Zhang
Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific reports 13 (1) (2023)
Junjie Zhang, Ran Xu, Qiang Lu, Zhenzhou Xu, Jianye Liu, Pei Li, Yaqun Zhang, Chuanchi Zhou, Lufeng Luo, Wei Tang, Zhenting Wang, Manman Cao, Jian Cao, Genming Xu, Long Wang
A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma. Cancers 15 (3) (2023)
Linfeng Li, Qidong Cai, Zeyu Wu, Xizhe Li, Wolong Zhou, Liqing Lu, Bin Yi, Ruimin Chang, Heng Zhang, Yuanda Cheng, Chunfang Zhang, Junjie Zhang
Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific reports 13 (1) (2023)
Wolong Zhou, Yuanda Cheng, Linfeng Li, Heng Zhang, Xizhe Li, Ruimin Chang, Xiaoxiong Xiao, Liqing Lu, Bin Yi, Yang Gao, Chunfang Zhang, Junjie Zhang
Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma. Journal of personalized medicine 13 (3) (2023)
Linfeng Li, Qidong Cai, Zeyu Wu, Xizhe Li, Wolong Zhou, Liqing Lu, Bin Yi, Ruimin Chang, Heng Zhang, Yuanda Cheng, Chunfang Zhang, Junjie Zhang
Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific reports 13 (1) (2023)
Linfeng Li, Qidong Cai, Zeyu Wu, Xizhe Li, Wolong Zhou, Liqing Lu, Bin Yi, Ruimin Chang, Heng Zhang, Yuanda Cheng, Chunfang Zhang, Junjie Zhang
Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific reports 13 (1) (2023)

Junjie Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Junjie Zhang